P3–359: Reduction of mitochondrial superoxide dismutase modulates Alzheimer's disease–like pathology in human amyloid precursor protein transgenic mice
Luke Esposito(Gladstone Institutes), Lennart Mucke(Gladstone Institutes), Eliezer Masliah(University of California San Diego), Jukka Puoliväli, Xin Wang(Capital Medical University), Kimberly Scearce‐Levie, Gui-Qiu Yu(Gladstone Institutes), Fengrong Yan(Gladstone Institutes)
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k